The 82-year-old was diagnosed with an aggressive form of prostate cancer in May, months after he left office and was replaced ...
To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...
The researchers argue that traditional vaccine development methods, which rely heavily on laboratory experimentation and long ...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, /PRNewswire/ -- ...
China has approved the world's first domestically developed drug designed to achieve a functional cure for hepatitis B, ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Arovella Therapeutics Limited ( ($AU:ALA) ) has provided an announcement. Arovella Therapeutics Ltd announced that its CEO, Dr. Michael Baker, ...
Researchers at UAQ are reporting promising developments in their efforts to produce a pioneering vaccine against screwworm in cattle.
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
Some officials want to split the MMR vaccine into separate shots for measles, mumps, and rubella. The science is clear: ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback